OraSure Technologies Appoints Gregory B. Lawless to Board of Directors
BETHLEHEM, Pa.--(BW HealthWire)--April 25, 2001--OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the appointment of Gregory B. Lawless to the Company's Board of Directors. This appointment increases the size of OraSure's Board to seven members.
Since 1998, Dr. Lawless has been the Managing Partner of Collins Mabry & Co., a strategic advisory firm for the life sciences industry, which he co-founded. From 1992 to 1998, Dr. Lawless served as President and Chief Executive Officer of Cygnus, Inc., a medical diagnostics company, and from 1989 to 1992, was President and Chief Operating Officer of Chiron Corporation, a biotechnology company.
"We welcome Greg to the OraSure board and look forward to his contributions," commented Robert D. Thompson, Chief Executive Officer for the Company. "With over 17 years of experience as a senior executive in the pharmaceutical, medical device and diagnostic industry, Greg is a significant addition to our Board."
Dr. Lawless received his B.S. in Pharmacy from Fordham University, his M.S. in Analytical Chemistry from St. John's University and his Ph.D. in Physical biochemistry from Temple University.
About OraSure Technologies
OraSure Technologies, Inc. develops, manufactures and markets medical devices and diagnostic products for use by public- and private-sector clients, clinical laboratories, physicians' offices and workplace testing. OraSure Technologies is the leading supplier of oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the company supplies oral fluid testing solutions for drugs-of-abuse testing. For more information on the company, please go to www.orasure.com.
CONTACT:OraSure Technologies, Inc.
Michelle Sells, 503/641-6115
Investorinfo@orasure.com
www.orasure.com
or
Rich Hooper, 610/882-1820
